Clinical Trial

Pain Comparison: Transrectal vs. Transperineal Prostate Biopsy

Study acronym: TRAP-PAIN
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 11, 2026 (before its estimated July 10, 2026 completion). Its status may not reflect the trial's current state.
Summary
Prostate biopsy remains the gold standard for the diagnosis of prostate cancer and is most commonly performed using either the transrectal or transperineal approach. Although both techniques offer acceptable diagnostic accuracy, the pain experienced during and after the procedure is an important factor influencing the choice of biopsy approach and overall patient comfort. Pain perception in prostate biopsy is multifactorial, depending on the biopsy route, the number of needle insertions, the local anesthesia protocol, and the innervation of the relevant anatomical structures. The aim of this prospective study is to compare anticipated (pre-procedural expected) and experienced (post-procedural actual) pain levels in patients undergoing transrectal versus transperineal prostate biopsy, using the Visual Analog Scale (VAS). Findings are expected to contribute to clinical decision-making regarding biopsy approach selection with a focus on patient comfort.
Trial Details
NCT Number NCT07577895
Lead Sponsor Kayseri Education and Research Hospital
Conditions Prostate Cancer
Enrollment 200 participants
Start Date 2026-05-10
Primary Completion 2026-07-10 (estimated)
Study Completion 2026-08-10 (estimated)
Updated on ClinicalTrials.gov 2026-05-11